Government News

4677 PMBJP Kendras functional in 35 States/UTs of the country by end of year 2018

  • Posted on: 12 January 2019
  • By: Shalini.Sharma

Minister of State for Road Transport and Highways, Shipping and Chemicals and Fertilizers, Shri Mansukh L. Mandaviya, while giving a written reply to a question in Rajya Sabha today, stated that as on 31.12.2018, 4677 ‘Pradhan Mantri Bhartiya Jan Aushadhi Pariyojana’ (PMBJP) Kendras are functional in 35 States/UTs of the country.

Central Government banned Buclizine's use as appetite stimulant due to lack of clinical trials

  • Posted on: 27 December 2018
  • By: PharmaTutor News

Central Government recognised that the use of the drug Buclizine as appetite stimulant for human use is not rational and due to lack of clinical trials Government prohibited the manufacture, sale and distribution of Buclizine for the indication “as appetite stimulant”.

Cabinet approves Allied and Healthcare Council of India and corresponding State Allied and Healthcare Councils

  • Posted on: 23 November 2018
  • By: Shalini.Sharma

The Union Cabinet chaired by Prime Minister Shri Narendra Modi has approved the establishment of an Allied and Healthcare Council of India and corresponding State Allied and Healthcare Councils which will play the role of standard-setters and facilitators for professions of Allied and Healthcare. Thanking the Prime Minister Shri Narendra Modi for his visionary leadership and constant guidance, Shri Nadda said that he is grateful to the Prime Minister for approving a landmark legislation which will provide employment opportunities to millions of youth in the country and will help standardize allied healthcare.

MoU signed on India-UK Cancer Research Initiative for Affordable Approaches to Cancer

  • Posted on: 16 November 2018
  • By: Shalini.Sharma

A Memorandum of Understanding (MoU) for the partnership between Department of Biotechnology and Cancer Research UK for the India-UK India-UK Cancer Research Initiative was signed today in New Delhi.The India-UK Cancer Research Initiative is a collaborative 5-year bilateral research initiative by the Department of Biotechnology, Ministry of Science & Technology, India and Cancer Research UK (CRUK) that will focus on affordable approaches to cancer. Both CRUK and DBT will invest £5m each in this 5-year pilot, and seek further investment from other potential funding partners.

Health Ministry has taken up several focused and targeted schemes for addressing nutrition challenges in the country: J P Nadda

  • Posted on: 16 November 2018
  • By: Shalini.Sharma

The Health Ministry has taken up several focused and targeted schemes for addressing nutrition challenges in the country in a convergence mode with the other Ministries.We have focussed on Immunisation, detection and supplementation.  This was stated by Shri J P Nadda, Union Minister for Health and Family Welfare at the 3rd meeting of the “National Council on India’s Nutrition Challanges” in presence of Smt Maneka Sanjay Gandhi, Minister of Women and Child Development.

IPA request Union health minister to include pharmacists into NPCDCS

  • Posted on: 13 November 2018
  • By: PharmaTutor News

The pharmacist have tremendous role to the improvement of public health. With this conviction, IPA decide to develop Public-Private-Partnership (PPA) agreement initiated by Indian Pharmaceutical Association (IPA) and Central TB Division (CTBD) in 2006 to explore the potential of pharmacists for TB control programme. The association has now mooted another proposal with the CTBD to tap the potential of the retail pharmacists working in community pharmacies and hospital pharmacies.

FDA took new steps to strengthen and modernize inspections for sterile injectable drugs

  • Posted on: 13 November 2018
  • By: PharmaTutor News

Manufacturing inspections are one of the FDA’s most important tools for ensuring the quality of pharmaceutical products used by American patients. Inspections help us to identify manufacturing issues that could pose potential risks to patients, or problems that could contribute to drug shortages, enabling us to engage manufacturers to address and resolve issues.

Pages